Neohesperidin Market

The Neohesperidin market is expected to grow at a CAGR of 6.1% from 2025 to 2035, driven by rising demand for natural flavonoids with antioxidant, anti-inflammatory, and sweetening properties. Neohesperidin is a bioflavonoid glycoside commonly extracted from citrus fruits, especially bitter oranges. It is extensively used as a flavor enhancer, antioxidant, and intermediate compound in pharmaceuticals and nutraceuticals. One of its most prominent derivatives, Neohesperidin Dihydrochalcone (NHDC), is a potent natural sweetener with applications in diabetic-friendly and low-calorie food products. Additionally, Neohesperidin exhibits strong anti-inflammatory and antiviral effects, making it a candidate in therapeutic research and dietary supplementation.

Geographically, Europe currently leads the global Neohesperidin market, driven by a strong inclination toward plant-based bioactives in food, cosmetic, and pharmaceutical formulations. Regulatory support from EFSA and consumer demand for natural ingredients support ongoing growth. North America follows closely, with increasing use in dietary supplements and functional food markets, particularly in the U.S. Asia-Pacific is witnessing rapid market expansion owing to increased adoption in traditional medicine, herbal products, and growing demand for clean-label sweeteners. Countries like China and India are also key producers of citrus-based raw materials.

The market report is evolving due to its dual-use profile in both health and flavoring applications. As consumer preferences shift toward safer, plant-based ingredients and regulatory scrutiny of artificial additives intensifies, Neohesperidin’s role in formulation science is expected to strengthen.